These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 1674631)

  • 1. A reply to critics of using stimulants to treat attention deficit hyperactivity disorder.
    Pliszka SR
    Tex Med; 1991 Apr; 87(4):84-7. PubMed ID: 1674631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Educators' knowledge and attitudes regarding stimulants in the treatment of attention deficit hyperactivity disorder.
    Kasten EF; Coury DL; Heron TE
    J Dev Behav Pediatr; 1992 Jun; 13(3):215-9. PubMed ID: 1351895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and medical treatment of ADHD in children and adolescents in primary care: a practical guide.
    Woodard R
    Pediatr Nurs; 2006; 32(4):363-70. PubMed ID: 16927730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
    Gruber R
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofeedback: an alternative and efficacious treatment for Attention Deficit Hyperactivity Disorder.
    Fox DJ; Tharp DF; Fox LC
    Appl Psychophysiol Biofeedback; 2005 Dec; 30(4):365-73. PubMed ID: 16385424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of patients with attention-deficit hyperactivity disorder by family practitioners.
    Eppright TD; Bradley S; Vogel SJ; Williamson HA
    Mo Med; 1998 Mar; 95(3):118-22. PubMed ID: 9529896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder.
    Ashton H; Gallagher P; Moore B
    J Psychopharmacol; 2006 Sep; 20(5):602-10. PubMed ID: 16478756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
    Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A reply concerning scientologists and ADHD: Scientific evidence and indications for treatment with methylphenidate].
    Zetterström R
    Lakartidningen; 2002 Mar; 99(14):1618-9. PubMed ID: 12025221
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 18. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tips for managing children with attention deficit hyperactivity disorder in the dental setting.
    Efron LA; Sherman JA
    N Y State Dent J; 2005 Apr; 71(3):18-20. PubMed ID: 16013678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.